First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation

Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

1996 • 6,822 citations

Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

1996 • 3,106 citations

Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival

2001 • 2,151 citations

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

1997 • 953 citations

IMMUNOPHARMACOLOGY OF RAPAMYCIN

1996 • 651 citations

RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.

1994 • 475 citations

TOR signalling and control of cell growth

1997 • 458 citations

Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

2004 • 358 citations

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

2002 • 305 citations

Independent risk factors and natural history of renal dysfunction in liver transplant recipients

2003 • 274 citations

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

2004 • 244 citations

De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects

2007 • 181 citations

Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection

2003 • 147 citations

Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines: An approach to suppress R5 strains of HIV-1

2003 • 125 citations

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection

2002 • 116 citations

HIV-1 Coreceptors and Their Inhibitors

2007 • 99 citations

The Immunosuppressant Rapamycin Represses Human Immunodeficiency Virus Type 1 Replication

2002 • 75 citations

Kaposi’s sarcoma after liver transplantation

2007 • 51 citations

Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis

2005 • 51 citations

Interleukin‐2 Up‐Regulates Expression of the Human Immunodeficiency Virus Fusion Coreceptor CCR5 by CD4⁺Lymphocytes In Vivo

2000 • 48 citations

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients

2004 • 47 citations

Mechanism of action of rapamycin (Sirolimus, Rapamune).

1996 • 40 citations

Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment

2007 • 33 citations

Induction of G ₁ cycle arrest in T lymphocytes results in increased extracellular levels of β-chemokines: A strategy to inhibit R5 HIV-1

2003 • 30 citations

Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro

2007 • 30 citations